The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1510
https://www.valueinhealthjournal.com/article/S1098-3015(17)31844-2/fulltext
Title :
The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31844-2&doi=10.1016/j.jval.2017.08.1510
First page :
A649
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1363